, Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection, Geneva: World Health Organization, 2018.

Z. Younossi, G. Papatheodoridis, P. Cacoub, F. Negro, H. Wedemeyer et al., The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease, J Viral Hepat, vol.25, issue.3, pp.6-14, 2018.

P. Halfon and P. Cacoub, Treatment of hepatitis C with new direct antiviral drugs: towards a disease cure

, Rev Med Interne, vol.35, issue.4, pp.219-240, 2014.

Q. L. Choo, G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley et al., Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, vol.244, pp.359-362, 1989.

G. Kuo, Q. L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker et al., An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science, vol.244, pp.362-364, 1989.

H. J. Alter, R. H. Purcell, J. W. Shih, J. C. Melpolder, M. Houghton et al., Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis, N Engl J Med, vol.321, pp.1494-1500, 1989.

P. Cacoub, T. Poynard, P. Ghillani, C. F. Olivi, M. Piette et al., Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum, 1999.
URL : https://hal.archives-ouvertes.fr/hal-01159323

F. Imbert-bismut, V. Ratziu, L. Pieroni, C. F. Benhamou, Y. Poynard et al., Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, vol.357, issue.9262, pp.1069-75, 2001.

I. M. Jacobson, P. Cacoub, D. Maso, L. Harrison, S. A. Younossi et al., Manifestations of chronic hepatitis C virus infection beyond the liver, Clin Gastroenterol Hepatol, vol.8, issue.12, pp.1017-1046, 2010.

R. Schinazi, P. Halfon, P. Marcellin, and T. Asselah, HCV direct-acting antiviral agents: the best interferon-free combinations, Liver Int, vol.34, pp.69-78, 2014.

P. Cacoub, M. Vautier, A. C. Desbois, A. Lafuma, and D. Saadoun, Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era, Liver Int, vol.37, issue.12, pp.1805-1813, 2017.

P. Cacoub, P. Buggisch, J. A. Carrión, G. S. Cooke, A. L. Zignego et al., Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe, J Viral Hepat, 2018.

C. S. Bang and I. H. Song, Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis, BMC Gastroenterol, vol.17, issue.1, p.46, 2017.

P. Cacoub, A. C. Desbois, C. Comarmond, and D. Saadoun, Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut, vol.67, pp.2025-2034, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01960761